Bezu, L., & Kroemer, G. High circulating HMGB1 indicates good prognosis in patients with advanced leiomyosarcoma under chemoimmunotherapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationBezu, Lucillia, and Guido Kroemer. High Circulating HMGB1 Indicates Good Prognosis in Patients with Advanced Leiomyosarcoma Under Chemoimmunotherapy. Taylor & Francis Group.
MLA (9th ed.) CitationBezu, Lucillia, and Guido Kroemer. High Circulating HMGB1 Indicates Good Prognosis in Patients with Advanced Leiomyosarcoma Under Chemoimmunotherapy. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.